Stay updated on Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial

Sign up to get notified when there's something new on the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site revision label changed from v3.8.0 to v3.8.1, with the clinical trial record otherwise unchanged.
    Difference
    0.1%
    Check dated 2026-11-21T14:38:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The record for the XMT-1522 Phase 1b study of patients with advanced HER2-expressing cancers is displayed, including participant criteria, study locations, treatment plan, outcome measures, and record dates.
    Difference
    40%
    Check dated 2026-11-07T14:09:55.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:18:13.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:03:34.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-17T20:19:55.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site revision marker changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:32:26.000Z thumbnail image

Stay in the know with updates to Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page.